Heparan sulfate proteoglycans and cancer

F. H. Blackhall, C. L R Merry, E. J. Davies, G. C. Jayson

    Research output: Contribution to journalArticlepeer-review

    Abstract

    Heparan sulfate proteoglycans (HSPGs) are widely distributed in mammalian tissues and involved in a number of processes related to malignancy. They are composed of a core protein to which chains of the glycosaminoglycan, heparan sulfate (HS), are attached. The existence of various classes of core protein, in addition to highly polymorphic HS chains, creates a superfamily of macromolecules with considerable diversity of structure and function. HSPGs interact with many proteins including growth factors, chemokines and structural proteins of the extracellular matrix to influence cell growth, differentiation, and the cellular response to the environment. The recent identification of two inherited syndromes that are associated with an increased cancer risk, and caused by mutations in HSPG-related genes, has intensified interest in these molecules. This review describes our current understanding of HSPGs in cancer and highlights new possibilities for therapeutic control. © 2001 Cancer Research Campaign.
    Original languageEnglish
    Pages (from-to)1094-1098
    Number of pages4
    JournalBritish Journal of Cancer
    Volume85
    Issue number8
    DOIs
    Publication statusPublished - 19 Oct 2001

    Keywords

    • Cancer
    • Heparan sulfate
    • Proteoglycans

    Fingerprint

    Dive into the research topics of 'Heparan sulfate proteoglycans and cancer'. Together they form a unique fingerprint.

    Cite this